Roy van der Meel
I am a biomedical engineer with expertise in nanomedicine and RNA therapeutics. After obtaining a PhD at a postdoc appointment from Utrecht University, I secured a Marie Skłodowska-Curie and NWO Veni funding for a postdoc at the University of British Columbia, at Pieter Cullis’ Lab. There, I developed lipid nanoparticle (LNP) technology for siRNA therapeutic and mRNA vaccines for COVID-19. I am currently an Assistant Professor in the Precision Medicine group at TU/e. My recent research is supported by NWO Vidi funding, and focuses on platform nanotechnology for delivering RNA therapeutics to specific immune cells and regulating the innate immune response. I have co-authored over 50 publications in leading nanotechnology journals including Nature Nanotechnology, Nature Biomedical Engineering, and ACS Nano.